Global Orthopedic Trauma Devices Market Overview:
Orthopedic trauma devices play a vital role in the surgical treatment of traumatic orthopedic injuries. A growing number of traumatic orthopedic injury cases and rising demand for the advanced facilities in orthopedic trauma, and surgery centers is expected to drive the market demand over the forecasted period. Technological advancements in orthopedic trauma devices and flexible trauma fixation devices are trending in the global market.
- Increase in Road Accidents and Severe Fracture Incidences Worldwide
- Prevalence of Rheumatoid Arthritis and Osteoarthritis
- Technological Advancements in the Orthopedic Trauma Device
- Rising Demand for Advanced Facility in Orthopedic Trauma and Surgery Centers from Developing Countries
- Growing Healthcare Expenditure in Emerging Countries
- Rising Awareness of 3D Printing Technology
- Lack of Awareness in Underdeveloped Countries
Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product offerings.
Some of the key players profiled in the report are Zimmer Biomet (United States), Globus Medical (United States), Johnson & Johnson (United States), Smith & Nephew Plc (United Kingdom), Stryker Corporation (United States), B. Braun (Germany), Colfax Corporation (United States), OsteoMed (United States), Invibio (United Kingdom) and BIOTEK (India). Additionally, following companies can also be profiled that are part of our coverage like CONMED (United States), Medtronic plc (Ireland) and Auxein Medical (India). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Orthopedic Trauma Devices market by 2025. Considering Market by Material , the sub-segment i.e. Bioabsorbable Materials (Polyglycolic Acid (PGA), Polylactic Acid (PLA), and others) will boost the Orthopedic Trauma Devices market. Considering Market by End User, the sub-segment i.e. Hospitals and Clinics will boost the Orthopedic Trauma Devices market.
In Oct 2019, Johnson & Johnson Medical (Shanghai) Ltd. announced that it has entered a co-marketing and distribution agreement, as well as an R&D agreement, with TINAVI. This strategic collaboration will allow DePuy Synthes1, the orthopedics business of Johnson & Johnson Medical Devices Companies*, to bring TINAVIís robotic solutions for spine and trauma surgery to the highly competitive China orthopedics implant market. To date, the system is the only arm-based robotic technology with multiple indications approved for use in spine and trauma in China.
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
Research Methodology:The top-down and bottom-up approaches are used to estimate and validate the size of the Global Orthopedic Trauma Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Orthopedic Trauma Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Orthopedic Trauma Devices Manufactures, Orthopedic Trauma Devices Suppliers/Distributors, Raw Material Suppliers, Ambulatory centers, Government and Private Laboratories, Research and Development (R&D) Companies, Market Research and Consulting Service Providers and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.